Health Technology · Pharmaceuticals: Major · NSE: SANOFI · data 2026-10-09
Sanofi India Limited
Health check: Average (5.8/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹2,945.4
Market cap
₹6,867 cr
P/E
21
P/B
8.2
ROE
40.6%
ROCE
54.6%
Debt / equity
0.02
Dividend yield
4.13%
1-year return
-38.2%
52-week high
₹4,898
52-week low
₹2,914.1
Operating margin
25.0%
Growth
| Revenue (last 12 months) | ₹1,805 cr |
| Net profit (last 12 months) | ₹324 cr |
| Sales growth, 3 years (yearly) | -12.8% |
| Profit growth, 3 years (yearly) | -19.3% |
Similar companies
Morepen Laboratories Limited (MOREPENLAB) · Bliss GVS Pharma Limited (BLISSGVS) · Symbiotec Pharmalab Limited (SYMBIOTEC) · Supriya Lifescience Limited (SUPRIYA) · Innova Captab Limited (INNOVACAP)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open SANOFI in NSE Scanner →